The Cleveland Clinic Foundation

Shuhui Wang Lorkowski

Stanley Leon Hazen

Jonathan D Smith

Provided herein are compositions, systems, kits, and methods for performing an apoA1 exchange assay to determine the risk of MACE and/or for conducting an action based on the assay results. In some embodiments, methods are provided for generating, or receiving, a report that graphically displays: i) the subjects ApoA1 exchange rate in a sample as lower than a control or threshold value, and ii) the subjects risk of a major adverse cardiac event (MACE) and/or cardiovascular disease as being higher than normal.

Growing community of inventors

Shaker Heights, OH, United States of America

Shuhui Wang Lorkowski